ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

China's Fosun revives buying spree with $1.26bn deal for Indian pharma

HONG KONG -- Less than a week after snapping up English football club Wolverhampton Wanderers, one of China's largest private conglomerates Fosun International struck another outbound deal with private Indian generic injectables maker Gland Pharma.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more